SANUWAVE Health, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE’s portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body’s normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Headquartered in Alpharetta, GA, SANUWAVE designs, manufactures, markets, and services its industry leading products worldwide.
We have already demonstrated that this technology is safe and effective in the European community for the stimulation of bone and chronic tendonitis regeneration in the musculoskeletal environment.
Our lead development product for the global wound care market, dermaPACE, has been CE Marked for use on acute and chronic defects of the skin and subcutaneous soft tissue.
Our musculoskeletal regenerative device, orthoPACE, launched in Europe for orthopedic, trauma and sports medicine indications in 2010.
We are now entirely focused on developing and commercializing this technology to stimulate tissue healing in all wound healing conditions to include DFU, decubitus ulcers (pressure sores), burns and other skin eruption conditions; orthopedic/spine applications such as fracture healing and fusion, creating improved bone density in osteoporosis and to eliminate chronic pain from trauma or arthritis; plastic/cosmetic applications such as cellulite smoothing, preconditioning for graft and transplant acceptance, skin tightening, scarring and other aesthetic uses; and potential developments in cardiac indications for removing plaque due to atherosclerosis and improving blood supply to the heart muscle.